These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 1310362

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients.
    Ramia S, Klayme S, Naman R.
    Ann Trop Med Parasitol; 2003 Mar; 97(2):187-92. PubMed ID: 12803874
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
    Smikle MF, Dowe G, Williams EM, Thesiger C.
    Hum Antibodies; 2000 Mar; 9(4):231-3. PubMed ID: 11341177
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso.
    Ouedraogo HG, Kouanda S, Grosso A, Compaoré R, Camara M, Dabire C, Ouedraogo R, Traore Y, Baral S, Barro N.
    Virol J; 2018 Dec 29; 15(1):194. PubMed ID: 30594218
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M, Chatterjee N, Zhang M, Battjes RJ, Goedert JJ.
    J Infect Dis; 2003 Sep 15; 188(6):891-7. PubMed ID: 12964121
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
    Candotti D, Mundy C, Kadewele G, Nkhoma W, Bates I, Allain JP.
    J Med Virol; 2001 Sep 15; 65(1):1-5. PubMed ID: 11505436
    [Abstract] [Full Text] [Related]

  • 32. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS, Chu A, Allain JP, Lee H, Cerney M, Nemoto T.
    N Y State J Med; 1991 Mar 15; 91(3):93-7. PubMed ID: 2047026
    [Abstract] [Full Text] [Related]

  • 33. HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
    Etzel A, Shibata GY, Rozman M, Jorge ML, Damas CD, Segurado AA.
    J Acquir Immune Defic Syndr; 2001 Feb 01; 26(2):185-90. PubMed ID: 11242188
    [Abstract] [Full Text] [Related]

  • 34. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991 Feb 01; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 35. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan 01; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.